Patents
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
11/2004
11/24/2004CN1177038C Halophilic and alkalophilic bacillus strain and its special plasmid and application
11/24/2004CN1176948C Single-chain antibody resisting HIV-1 outer membrane protein and recombinant immunotoxin
11/24/2004CN1176943C Novel recombinant human tissue factor pathway inhibitor active peptide and its preparation method
11/24/2004CN1176577C Nucleotide series of coded insecticidal crystalline protein and its application
11/23/2004US6822144 Methods for Agrobacterium-mediated transformation
11/23/2004US6822142 Transgenic plants containing altered levels of steroid compounds
11/23/2004US6822141 Diacylglycerol acyl transferase proteins
11/23/2004US6822140 Compositions and methods for fumonisin detoxification
11/23/2004US6822139 Modulation of storage organs
11/23/2004US6822138 NIK-knockout mice
11/23/2004US6822137 Nucleotide sequence encoding the enzyme I-SCEI and the uses thereof
11/23/2004US6822087 For anti-asthma/allergy/hypereosinophilia/inflammation/ cancer/tumor drugs; gene expression inhibition
11/23/2004US6822083 TSA305 gene
11/23/2004US6822082 Polynucleotides for mammalian secreted protein, Z1055G2P
11/23/2004US6822080 For identification/cloning/drug screening; enzyme inhibitors
11/23/2004US6822079 Regulates plant nitrogen metabolism; engineered plants that overexpress or underexpress p-pii regulatory protein may have increased nitrogen assimilation capacity
11/23/2004US6822077 Altering ku80 levels in plants; recobinant expression cassettes
11/23/2004US6822075 Protein for use in the diagnosis and treatment of autoimmune, cancer and viral disorders
11/23/2004US6822072 For diagnostics/forensics/gene therapy/chromosome mapping; expression vector design/secretion
11/23/2004US6821957 Vectors containing neutralizing motifs and/or a reduced number of immunostimulatory cpg motifs and methods of use for gene therapy protocols
11/23/2004US6821956 Oligodeoxynucleotide decoys for the prophylactic or therapeutic treatment of diseases associated with the binding of endogenous transcription factors to genes involved in cell growth, differentiation and signalling or to viral genes.
11/23/2004US6821955 Immobilized vaccine; gene therapy
11/23/2004US6821948 Conjugate for mediating cell, compartment or membrane-specific transport of active substances
11/23/2004US6821946 Treating nerve damage; administer insulin like growth factor isoform to human, monitor response of damaged nerves
11/23/2004US6821789 Method and device for collecting and stabilizing a biological sample
11/23/2004US6821782 Selecting an explant of living tissue from the plant and cultivating the tissue on a primary medium to produce totipotent tissue
11/23/2004US6821781 Increased methional levels for improved flavor stability/quality during food processing; genetic engineering
11/23/2004US6821777 Cell line preparing and producing ovine adenovirus vectors
11/23/2004US6821776 Reconstituting retroviral vector (recon vector) for targeted gene expression
11/23/2004US6821775 Viral vector encoding pigment epithelium-derived factor
11/23/2004US6821769 Nucleotide sequences coding polypeptide for use in the prevention of bacterial infections
11/23/2004US6821767 Androgen receptor proteins, recombinant DNA molecules coding for such, and use of such compositions
11/23/2004US6821766 Thermostable creatine amidinohydrolase and process for producing the same
11/23/2004US6821764 Genes encoding sulfate assimilation proteins
11/23/2004US6821763 Process for producing microbial transglutaminase
11/23/2004US6821760 Comprising treating ammonium fumarate solution with aspartase
11/23/2004US6821759 Methods of performing homologous recombination based modification of nucleic acids in recombination deficient cells and use of the modified nucleic acid products thereof
11/23/2004US6821758 Method for the production of biopolymers with modified properties
11/23/2004US6821757 Rapid and simple process for isolation of circular nucleic acids
11/23/2004US6821754 Staphylococcus aureus genes and polypeptides
11/23/2004US6821753 Replication incompetent herpes viruses for use in gene therapy
11/23/2004US6821752 Methods and compositions for extracting proteins from cells
11/23/2004US6821751 Hypoxia responsive transcription enhancer element from yeast
11/23/2004US6821750 ABCG8 vectors, host cells, and method of making
11/23/2004US6821749 Methods of producing carotenoids using DNA molecules encoding isopentenyl pyrophosphate isomerase
11/23/2004US6821745 Regulation of human pyroglutamyl peptidase-like enzyme
11/23/2004US6821743 Membrane protein for use in controlling vasodilation
11/23/2004US6821742 Conformational and topological protein regulation
11/23/2004US6821741 Cells for detection of enteroviruses
11/23/2004US6821735 Protein involved in abscisic acid signalling
11/23/2004US6821734 Detecting restriction fragment length polymorphisms with chemiluminescent probes
11/23/2004US6821731 Expression analysis of FKBP nucleic acids and polypeptides useful in the diagnosis of prostate cancer
11/23/2004US6821728 Screening system
11/23/2004US6821726 Method for quantitatively analyzing tumor cells in a body fluid and test kits suited therefor
11/23/2004US6821723 Polypeptide mimics the intermediate state of gp41 and is capable of inducing antibodies which neutralize primary isolates of hiv
11/23/2004US6821692 Kind of thin films for microsystem technology and microstructuring and their use
11/23/2004US6821519 Comprises polypeptide for detecting viral infection; immunoassays; immunostimulant
11/23/2004US6821512 Selective packaging of the adenovirus (ad) genome into viral capsids
11/23/2004US6821511 Transducing cell; incubate cells with nucleotide sequences, insert cells into mammals, monitor mammals for phenotypic adjustment
11/23/2004US6821406 Method for surface treatment of gold-plated body and surface-treated product, and process for producing gold-plated body and gold-plated body, and method for immobilization of sulfur-containing molecules
11/23/2004US6821402 Spectral calibration of fluorescent polynucleotide separation apparatus
11/23/2004CA2242035C Compositions useful for transferring therapeutically active substances into a target cell, and their use in gene therapy
11/23/2004CA2116026C Hepatitis c assay utilizing recombinant antigens to c-100 region
11/23/2004CA2084076C Family of map2 protein kinases
11/23/2004CA2012482C Hepatitis c diagnostics and vaccines
11/23/2004CA1341465C Herbicide resistance in plants
11/22/2004CA2441681A1 Cancer monitoring and therapeutics
11/22/2004CA2429235A1 Cloning vector with a blunt-end insert for use in positive selection of recombinant clones, cloning method for the said vector, use of the said vector for the expression of an insert
11/21/2004CA2467610A1 Method for the detection of nucleic acids
11/18/2004WO2004099447A2 Corn event tc1507 and methods for detection thereof
11/18/2004WO2004099441A2 Selection and evolution of chemical libraries
11/18/2004WO2004099423A1 Vp2-modified raav vectors and uses thereof
11/18/2004WO2004099422A2 Adenovirus particles with enhanced infectivity of dendritic cells and particles with decreased infectivity of hepatocytes
11/18/2004WO2004099421A1 Multiple gene transcription activity determining sysyem
11/18/2004WO2004099420A1 Minicircle vector production
11/18/2004WO2004099418A1 Fused protein
11/18/2004WO2004099417A1 Genetic sequences of plant pathogen avirulence genes and uses therefor
11/18/2004WO2004099416A1 Dna fragment specific to cytoplasmic male sterile pepper and use thereof
11/18/2004WO2004099415A1 A new stress-resistance transcription factor (capf1) gene, its protein and a transfected plant by the gene
11/18/2004WO2004099414A1 Plant cad3-like genes and their use
11/18/2004WO2004099413A1 Plant cad2-like genes and their use
11/18/2004WO2004099412A1 Nucleic acid molecules differentially expressed in animals exhibiting behavioural disorders
11/18/2004WO2004099411A1 A method for dissecting the rna secondary structure dependence of rna-ligand interactions
11/18/2004WO2004099409A1 Process for extracting nucleic acid
11/18/2004WO2004099408A1 Novel protein and dna coding for the same
11/18/2004WO2004099405A1 Human blood proteins expressed in monocot seeds
11/18/2004WO2004099404A2 Bioinformatic method for predicting functional equivalence between biological sequences
11/18/2004WO2004099403A1 A method of increasing the total or soluble carbohydrate content or sweetness of an endogenous carbohydrate by catalysing the conversion of an endogenous sugar to an alien sugar.
11/18/2004WO2004099402A1 Glycosylation variants of bace
11/18/2004WO2004099401A1 Variant subtilisin enzymes (subtilases)
11/18/2004WO2004099400A2 Variant lipolytic ensymes
11/18/2004WO2004099399A1 Glucose dehydrogenase and production thereof
11/18/2004WO2004099392A1 Transfection method for mammalian cells
11/18/2004WO2004099388A2 Cbl-b polypeptides, complexes and related methods
11/18/2004WO2004099387A2 siRNA INDUCED SYSTEMIC GENE SILENCING IN MAMMALIAN SYSTEMS
11/18/2004WO2004099385A2 Telomere elongation
11/18/2004WO2004099384A2 Solid phase cell lysis and capture platform
11/18/2004WO2004099381A2 Genetically modified yeast species and fermentation processes using genetically modified yeast
11/18/2004WO2004099377A2 An autologous upregulation mechanism allowing optimized cell type-specific and regulated gene expression cells
11/18/2004WO2004099372A2 Anti-scarring ribozymes and methods